Influenza-Induced Activation of Recruited Alveolar Macrophages During the Early Inflammatory Phase Drives Lung Injury and Lethality

Authors:
  • KAKishore R. Anekalla
    Kishore R. Anekalla
  • YHYuan-Shih Hu
    Yuan-Shih Hu
  • JDJennifer M. Davis
    Jennifer M. Davis
  • MCMark Ciesielski
    Mark Ciesielski
  • GGGaurav Gadhvi
    Gaurav Gadhvi
  • SCShang-Yang Chen
    Shang-Yang Chen
  • MTMargaret Turner
    Margaret Turner
  • YCYuan Cheng
    Yuan Cheng
  • BCBria M. Coates
    Bria M. Coates
  • HAHiam Abdala-Valencia
    Hiam Abdala-Valencia
  • PRPaul A. Reyfman
    Paul A. Reyfman

Abstract
Severe respiratory virus infections initiate a robust host immune response that contributes to disease severity. Immunomodulatory strategies that limit virus-initiated inflammation are of critical importance. In this study, we compared the host response to influenza A virus (IAV) infection in susceptible animals (wild-type, WT) to resilient mice (Vimentin-/- mice). We identified distinct gene expression patterns in recruited monocyte-derived alveolar macrophages (MoAMs) associated with three phases (Infiltrating, Early Inflammatory, Late Inflammatory) that evolve in sequence over the course of IAV infection. We report a core set of pro-inflammatory genes involved in the WT MoAM Early Inflammatory response that is suppressed in Vim -/- MoAMs. Moreover, we identify CEBPB, Jun-AP1, and IRF transcriptions factors as regulators of this attenuated inflammatory response. We performed causal experiments using bone-marrow chimeras to credential that Vim-/- MoAMs with suppressed pro-inflammatory genes confer protection from influenza-induced mortality in WT susceptible mice. Taken together, these data support the notion that vimentin plays a causal role in determining the pro-inflammatory function of recruited MoAMs and drives IAV-induced lung injury.